API
Stock Code
Stock Exchange
Australian Pharmaceutical Industries (API) was formed in 1910 and now it is a leading distributor of pharmaceutical and allied products in Australia having alliances with more than 4000 independent pharmacies. API also focuses on retailing through its wholly owned Priceline retail store brand, a major health and beauty brand in Australia. API is a major franchisor in the pharmacy industry. Through its 150 Priceline Pharmacy stores, API offers the pharmacist franchisees a total retail model. The Company listed on the Australian Stock Exchange on 16 June, 1997.
The sharemarket would not be so busy on Tuesday as there would only be two scheduled events on January 17, 2012--a float and an Annual General Meeting.
Float
- Highfield Resources (ASX: HFR) has issued a price of 20 cents per ordinary share to raise a capital of $4 million.
Stock Filter of the All Ordinaries Losers this week, on the Australian Securities Exchange (ASX) this 49th week: 6th December to 10th December 2010. These stocks decreased their stock price by the biggest percentage on the Australian stockmarket. All Ordinaries Stocks Losers this week include: API, TRS, DTE, PVE, BOC, MPO, KAM, CER, FRI, ISF, IAU, NBS, GRR. Other lists of Aussie companies by market capitalisation.
Pharmaceuticals conglomerate, Pfizer have decided to distribute its products directly to chemists.
Peruse the dividend history for AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED. A taxable payment declared by a company's board of directors and given to its shareholders out of the company's current or retained earnings, usually quarterly. Dividends are usually given as cash (cash dividend), but they can also take the form of stock (stock dividend) or other property. Dividends provide an incentive to own stock in stable companies even if they are not experiencing much growth. Companies are not required to pay dividends.
Sigma Pharmaceutical (SIP) is bidding for Australian Pharmaceutical Industries (API), a pharmaceutical wholesaler. Sigma Pharmaceutical have announced a bid of $2.20 per share for Australian Pharmaceutical Industries but the market expects another bid as shares surge in API. Stock analyst, Macquarie Research Equities (MRE) said that "expect further bidding to continue, with the key question remaining how much one would pay." MRE expects to see further bidding to continue and likely to come from Symbion (SYB).
Deutsche Bank have rated the Australian Pharmaceutical Industries (API) stock with a Hold recommendation dropping their share price target from $3 to $2. The broker notes that there is nothing good to say about the stock and even the stock price weakness finds no opportunities. Risks in the business include margin pressure, weak PBS funding growth and excess competition.
ABN Amro has rated the Australian Pharmaceutical Industries (API) stock as Hold, lowering their share price target from $2.81 to $2.37. Australian Pharmaceutical Industries is listed on the Australian Stock Exchange (ASX) under stock code API. Check your charts!
- How to Trade Forex and Gold Options
- How to Trade the Gold Price and Profit!
- Forex Trading the EUR/USD Pair € EURO and $ US Dollar
- How to Trade Stock Market Indices S&P500
- How to Trade Crude Oil
- Forex Trading Psychology
- What Are Broker Recommendations?
- Free Tickets to Trading & Investing Seminar & Expo ($18) Brisbane 2013
- Stock Calc App
- All About Warrants
- Introduction to Exchange Traded Funds
- Introduction to Exchange Traded Funds: Features
- Introduction to Exchange Traded Funds: Domestic ETFs
- Introduction to Exchange Traded Funds: International ETFs
- Exchange Traded Commodities
- Australian Stock Scan
- Australian Online Share Trading
- List of Trading Books
- Interesting Thoughts about the Australian Dollar
- What's the Meaning of Hawkish?
- Do You Know How To Use the P/E Ratio
- Trading, Religion and Politics - Do They Have Anything in Common?
- Shares that are Volatile that Double and Half in the Short Term
- Telstra (TLS) T3
- Margin Call by E-mail
- The Cost of Holding a Position
- Lack of Disclosure: Compensation from ASX Listed Company
- Unrealistic Returns and Benchmarks
- CMC Markets Down
- Quality versus Quantity Forex Trading
- Woolworths 1H Sales $30.7bn up 3.2%
Date added 31-01-2013 - ASIC Fines CommBank's CommSec
Date added 25-09-2012 - Industry Super Network Calls to Ban High Frequency Trading (HFT)
Date added 22-09-2012 - NAB Launches Online Share Trading Platform
Date added 19-09-2012 - Reserve Bank of Australia Says 23 Countries Holding AUD
Date added 18-09-2012 - Australia Post Digital Mailbox
Date added 10-09-2012 - Winners and Losers of Trading for Week 2
Date added 16-01-2012 - 2012's First Week of the Best and Worst Traded Stocks
Date added 09-01-2012 - 2011's Last Best and Worst Traded Stocks
Date added 05-01-2012 - Best and Worst Pre-Christmas Traded Stocks
Date added 30-12-2011 - Trading Winners and Losers for Dec. 12-16
Date added 19-12-2011 - Best and Worst Traded Stocks for Dec. 5-9
Date added 13-12-2011 - Top 3 Best and Worst Traded Stocks
Date added 05-12-2011 - ASX Glitch Trading Halt
Date added 27-10-2011 - Worst Trade Stocks (and the Best)
Date added 06-08-2011
Top 150 Public Companies Listed on the Australian Stockmarket as at 29/05/2009
- BHP Billiton
- Westpac Banking Corporation (WBC)
- Commonwealth Bank of Australia (CBA)
- National Australia Bank (NAB)
- Telstra (TLS)
- ANZ
- News Corporation (NWS)
- Woolworths Limited(WOW)
- Woodside Petroleum Limited (WPL)
- Rio Tinto
- Westfield Group (WDC)
- Westfarmers Limited (WES)
- QBE Insurance
- CSL
- Newcrest Mining Limited (NCM)
- Origin Energy Limited (ORG)
- Santos Limited (STO)
- AMP Limited (AMP)
- Macquarie Group (MQG)
- Foster’s Group Limited (FGL)
